Summary
Plasminogen Activator (PA) and its response to glucocorticoids and androgens was studied in viable rat thymocytes in suspension. PA was measured by its ability to convert plasminogen to plasmin, and the formed plasmin determined by cleavage of 14C-labeled globin. Using this functional assay, PA was found to be associated with the outer surface of thymic cells, and only negligible activity recovered from the incubation medium. Rat thymocytes also contain cytoplasmic and nuclear inhibitor(s) of the serine proteases plasmin, trypsin, chymotrypsin and thymic PA. Release of these inhibitors prevented determination of thymic PA activity in presence of lysed cells.
The specific activity of PA in thymocytes isolated from adrenalectomized-castrated rats did not differ significantly from the specific activity associated with cells from intact animals. Furthermore, treatment of adrenalectomized-castrated rats with 0.1 mg of dexamethasone/ kg for 2 days induced thymic involution without affecting thymic PA activity. These observations suggest that PA activity of thymocytes is not involved in glucocorticoid-mediated thymic involution.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Reich E: Plasminogen activator: Secretion by neoplastic cells and macrophages. In E Reich, DB Rifkin and E Shaw (eds) Proteases and Biological Control. Cold Spring Harbor Conference on Cell Proliferation, Cold Spring Harbor Laboratory, 1975, pp 333–341.
Christmas JK, Silverstein SC, Acs G: Plasminogen activators. In AJ Barrett (ed) Proteinases in Mammalian Cells and Tissues. Elsevier/North Holland, Amsterdam, New York, 1977, pp 91–149.
Ossowski L, Beigel D, Reich E: Mammary plasminogen activator: Correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell 16:929–940, 1979.
Holzer H, Heinrich PC: Control of Proteolysis. Ann Rev Biochem 49:63–91, 1980.
Coleman PL, Barouski PA, Gelehrter TD: The dexamethasone-induced inhibitor of fibrinolytic activity in hepatoma cells. J Biol Chem 257:4260–4264, 1982.
Mayer M, Galili UG, Kaiser N: Intracellular protease activity in glucocorticoid-mediated thymolysis. Endocrinology 110:2131–2137, 1982.
Munck A, Young DA: Corticosteroids and lymphoid tissue. In H Blaschko, G Sayers and AD Smith (eds) Handbook of Physiology. American physiological Society, Washington, DC, 1975, Section 7, Vol. 7, pp 231–243.
Aikman AA, Wills ED: Studies on lysosomes after irradiation. II. Lysosomal membrane permeability and acid phosphatase activity of lymphoid and other tissues after wholebody irradiation. Radiat Res 5:416–430, 1974.
Rosen F, Kaiser N, Mayer M, Milholland RJ: Glucocorticoids: Receptors and mechanisms of action in lymphoid tissues and muscle. In H Busch (ed) Methods in Cancer Research. Academic Press, New York, 1976, Vol 13, pp 67–100.
Hallak GJ, Wilkinson JH: Action of adenosine phosphates on the release of intracellular lactate dehydrogenase from human and rat lymphocytes. Enzyme 22:361–369, 1977.
Philips HJ: Dye exclusion tests for cell viability. In RF Kruse and MK Patterson (eds) Tissue Culture Methods and Applications. Academic Press, New York, 1973, pp 406–408.
Roth JA, Losty K, Wierbicki E: Assay of proteolytic enzyme activity using a 14C-labeled hemoglobin. Anal Biochem 42:214–221, 1971.
Sasson S, Mayer M: Effect of androgenic steroids on rat thymus and thymocytes in suspension. J Ster Biochem 14:509–517, 1981.
Quigley JP: Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells. J Cell Biol 71:472–486, 1976.
Loskutoff DJ, Edgington TS: Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci USA 74:3903–3907, 1977.
Goldsmith GH, Ziats NP, Robertson AL: Studies on plasminogen activator and other proteases in subcultured human vascular cells. Exper Molec Pathol 35:257–264, 1981.
Festoff BW, Patterson MR, Romstedt K: Plasminogen activator: The major secreted neutral protease of cultured skeletal muscle cells. J Cell Physiol 110:190–195, 1982.
Vassalli JD, Hamilton J, Reich E: Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors and cyclic nucleotides. Cell 8:271–281, 1976.
Mak TW, Rutledge G, Sutherland DA: Androgen-dependent fibrinolytic activity in a murine mammary carcinoma (Shionogi SC-115 Cells) in vitro. Cell 7:223–226, 1976.
Failly-Crepin C, Fromont S, Crepin M: Dexamethasone effect on the growth rate, the plasminogen activator and the MMTV RNA dependent DNA polymerase in a mouse mammary tumor cell line. Biochem Biophys Res Commun 102:22–29, 1981.
Holmberg L, Lecander I, Persson B, Astedt B: An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture. Biochim Biophys Acta 544:128–137, 1978.
Seifert SC, Gelehrter TD: Mechanism of dexamethasone inhibition of plasminogen activator in rat hepatoma cells. Proc Natl Acad Sci USA 75:6130–6133, 1978.
Crutchley DJ, Conanan CB, Meynard JR: Human fibroblasts produce inhibitor directed against plasminogen activator when treated with glucocorticoids. Ann NY Acad Sci 370:609–616, 1981.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mayer, M., Finci, Z., Kanaany, J. et al. Plasminogen activator and protease inhibitor activities in isolated rat thymocytes. Mol Cell Biochem 66, 137–144 (1985). https://doi.org/10.1007/BF00220781
Issue Date:
DOI: https://doi.org/10.1007/BF00220781